Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.
A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.
Erin Sharoni joins Ethics Talk to discuss her article: “Which Concepts Are Key to Transitioning From Nonhuman Animal Models to Engineered Microphysiological Systems in Biomedical Research?”
Dr Maeve Pascoe joins Ethics Talk to discuss her article, coauthored with Dr Nancy Foldvary-Schaefer: “Who Should Talk to Patients and How About Whether They Have Access to Sufficient, Quality Sleep?”
Maeve Pascoe, MD, MS and Nancy Foldvary-Schaefer, DO, MS
Poor sleep affects nearly every organ system and influences many morbidity and mortality causes, so screening for sleep sufficiency and quality should be prioritized.
AMA J Ethics. 2024; 26(10):E749-754. doi:
10.1001/amajethics.2024.749.